Annual Total Assets
$355.18 M
+$174.83 M+96.93%
December 31, 2023
Summary
- As of February 8, 2025, EYPT annual total assets is $355.18 million, with the most recent change of +$174.83 million (+96.93%) on December 31, 2023.
- During the last 3 years, EYPT annual total assets has risen by +$263.47 million (+287.26%).
- EYPT annual total assets is now at all-time high.
Performance
EYPT Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$300.92 M
-$23.33 M-7.20%
September 30, 2024
Summary
- As of February 8, 2025, EYPT quarterly total assets is $300.92 million, with the most recent change of -$23.33 million (-7.20%) on September 30, 2024.
- Over the past year, EYPT quarterly total assets has increased by +$140.87 million (+88.02%).
- EYPT quarterly total assets is now -15.28% below its all-time high of $355.18 million, reached on December 31, 2023.
Performance
EYPT Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
EYPT Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +96.9% | +88.0% |
| 3 y3 years | +287.3% | +66.8% |
| 5 y5 years | +354.4% | +66.8% |
EYPT Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +96.9% | -15.3% | +94.7% |
| 5 y | 5-year | at high | +386.8% | -15.3% | +331.8% |
| alltime | all time | at high | +7426.5% | -15.3% | +6142.6% |
EyePoint Pharmaceuticals Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $300.92 M(-7.2%) |
| Jun 2024 | - | $324.25 M(-1.5%) |
| Mar 2024 | - | $329.25 M(-7.3%) |
| Dec 2023 | $355.18 M(+96.9%) | $355.18 M(+121.9%) |
| Sep 2023 | - | $160.04 M(-8.9%) |
| Jun 2023 | - | $175.66 M(+13.6%) |
| Mar 2023 | - | $154.59 M(-14.3%) |
| Dec 2022 | $180.36 M(-31.5%) | $180.36 M(-18.2%) |
| Sep 2022 | - | $220.49 M(-5.5%) |
| Jun 2022 | - | $233.43 M(-4.5%) |
| Mar 2022 | - | $244.56 M(-7.1%) |
| Dec 2021 | $263.37 M(+187.2%) | $263.37 M(+56.5%) |
| Sep 2021 | - | $168.25 M(-5.9%) |
| Jun 2021 | - | $178.82 M(-4.4%) |
| Mar 2021 | - | $187.14 M(+104.0%) |
| Dec 2020 | $91.72 M(+25.7%) | $91.72 M(+19.4%) |
| Sep 2020 | - | $76.79 M(+10.2%) |
| Jun 2020 | - | $69.69 M(-13.2%) |
| Mar 2020 | - | $80.29 M(+10.0%) |
| Dec 2019 | $72.97 M(-6.6%) | $72.97 M(-7.7%) |
| Sep 2019 | - | $79.07 M(-13.4%) |
| Jun 2019 | - | $91.33 M(+11.6%) |
| Mar 2019 | - | $81.85 M(-7.9%) |
| Dec 2018 | $78.17 M(+9.1%) | - |
| Sep 2018 | - | $88.86 M(+24.0%) |
| Jun 2018 | $71.67 M(+283.7%) | $71.67 M(+42.9%) |
| Mar 2018 | - | $50.16 M(+253.3%) |
| Dec 2017 | - | $14.20 M(+6.5%) |
| Sep 2017 | - | $13.33 M(-28.6%) |
| Jun 2017 | $18.68 M(-40.9%) | $18.68 M(+6.7%) |
| Mar 2017 | - | $17.50 M(-11.3%) |
| Dec 2016 | - | $19.75 M(-20.8%) |
| Sep 2016 | - | $24.93 M(-21.1%) |
| Jun 2016 | $31.62 M(-2.3%) | $31.62 M(-12.6%) |
| Mar 2016 | - | $36.16 M(+51.0%) |
| Dec 2015 | - | $23.95 M(-12.8%) |
| Sep 2015 | - | $27.46 M(-15.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | $32.37 M(+42.8%) | $32.37 M(-9.3%) |
| Mar 2015 | - | $35.70 M(-11.1%) |
| Dec 2014 | - | $40.18 M(-8.1%) |
| Sep 2014 | - | $43.74 M(+92.9%) |
| Jun 2014 | $22.67 M(+39.5%) | $22.67 M(-12.9%) |
| Mar 2014 | - | $26.02 M(+25.0%) |
| Dec 2013 | - | $20.82 M(-8.4%) |
| Sep 2013 | - | $22.73 M(+39.9%) |
| Jun 2013 | $16.25 M(-21.1%) | $16.25 M(-15.0%) |
| Mar 2013 | - | $19.12 M(-9.1%) |
| Dec 2012 | - | $21.04 M(-9.8%) |
| Sep 2012 | - | $23.34 M(+13.3%) |
| Jun 2012 | $20.60 M(-56.3%) | $20.60 M(-9.8%) |
| Mar 2012 | - | $22.83 M(-8.5%) |
| Dec 2011 | - | $24.95 M(-42.2%) |
| Sep 2011 | - | $43.14 M(-8.4%) |
| Jun 2011 | $47.11 M(+9.5%) | $47.11 M(+0.4%) |
| Mar 2011 | - | $46.94 M(+14.5%) |
| Sep 2010 | - | $41.00 M(-4.7%) |
| Jun 2010 | $43.01 M(+15.9%) | $43.01 M(+43.8%) |
| Mar 2010 | - | $29.92 M(-8.3%) |
| Dec 2009 | - | $32.63 M(-5.4%) |
| Sep 2009 | - | $34.49 M(-7.0%) |
| Jun 2009 | $37.10 M(-33.5%) | $37.10 M(+2.0%) |
| Mar 2009 | - | $36.37 M(-7.3%) |
| Dec 2008 | - | $39.23 M(-16.8%) |
| Sep 2008 | - | $47.16 M(-15.5%) |
| Jun 2008 | $55.78 M(-45.6%) | $55.78 M(-51.9%) |
| Mar 2008 | - | $115.87 M(+7.6%) |
| Dec 2007 | - | $107.67 M(-7.4%) |
| Sep 2007 | - | $116.33 M(+13.5%) |
| Jun 2007 | $102.50 M(-41.4%) | $102.50 M(+5.0%) |
| Dec 2006 | - | $97.60 M(-44.2%) |
| Jun 2006 | $174.85 M(+150.6%) | $174.85 M(+150.6%) |
| Jun 2005 | $69.76 M(+148.7%) | $69.76 M(+148.7%) |
| Jun 2004 | $28.05 M(+481.9%) | $28.05 M(+481.9%) |
| Jun 2003 | $4.82 M(+2.1%) | $4.82 M |
| Jun 2001 | $4.72 M | - |
FAQ
- What is EyePoint Pharmaceuticals annual total assets?
- What is the all time high annual total assets for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals annual total assets year-on-year change?
- What is EyePoint Pharmaceuticals quarterly total assets?
- What is the all time high quarterly total assets for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals quarterly total assets year-on-year change?
What is EyePoint Pharmaceuticals annual total assets?
The current annual total assets of EYPT is $355.18 M
What is the all time high annual total assets for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high annual total assets is $355.18 M
What is EyePoint Pharmaceuticals annual total assets year-on-year change?
Over the past year, EYPT annual total assets has changed by +$174.83 M (+96.93%)
What is EyePoint Pharmaceuticals quarterly total assets?
The current quarterly total assets of EYPT is $300.92 M
What is the all time high quarterly total assets for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high quarterly total assets is $355.18 M
What is EyePoint Pharmaceuticals quarterly total assets year-on-year change?
Over the past year, EYPT quarterly total assets has changed by +$140.87 M (+88.02%)